期刊文献+

抗凝治疗中的困惑与应对 被引量:3

Solving the Puzzles of Anticoagulation Therapy
下载PDF
导出
摘要 在抗凝治疗中,临床医生常会遇到一些无法从各种抗凝指南或共识中直接获解的问题,包括传统抗凝药物和新型抗凝药物的适用范围、不同抗凝阶段和特殊情况下的抗凝药物选择、抗凝疗程的确定和并发症的防治,需要医生根据所学知识和临床经验,并通过查阅文献给出个体化的解决方案。本文针对上述问题提出几点见解。 During the clinical practice of anticoagulation therapy,some puzzles,including the choice between traditional anticoagulants and novel alternatives,options of anticoagulants in different phases of the therapy or under exceptional circumstances,the determination of anticoagulation course,and management of complications,cannot be solved by consulting guidelines or consensuses.The individual regimen should be worked out by physicians according to their knowledge and clinical experiences,or by reviewing the literature.Several opinions were given in this article,aiming to provide a further understanding of above questions.
作者 赵永强 ZHAO Yong-qiang(Department of Hematology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences &Peking Union Medical College, Beijing 100730, China)
出处 《协和医学杂志》 2018年第2期103-107,共5页 Medical Journal of Peking Union Medical College Hospital
关键词 抗凝治疗 传统抗凝药物 新型抗凝药物 并发症 anticoagulation therapy traditional anticoagulants novel anticoagulants complication
  • 相关文献

参考文献5

二级参考文献119

  • 1胡大一,张鹤萍,孙艺红,姜立清.华法林与阿司匹林预防非瓣膜性心房颤动患者血栓栓塞的随机对照研究[J].中华心血管病杂志,2006,34(4):295-298. 被引量:162
  • 2邹治鹏,何建国,程显声,赵彦芬,陈白屏,高莹,熊长明,倪新海,荆志诚.230例急性肺动脉血栓栓塞症患者对症治疗、抗凝治疗和溶栓治疗的住院转归[J].中国循环杂志,2006,21(3):219-221. 被引量:27
  • 3马艳,张庆华.新疆维吾尔族正常人群抗活化的蛋白C发生率的调查[J].中华血液学杂志,1996,17(9):468-468. 被引量:5
  • 4Ost D,Tepper J,Mihara H,et al.Duration of anticoagulation following venous thromboembolism:a meta-analysis.JAMA,2005,294 (6):706-715.
  • 5van Dongen CJ,Vink R,Hutten BA,et al.The incidence of recurrent venous thromboembolism after treatment with vitamin K antagonists in relation to time since first event:a meta-analysis.Arch Intern Med,2003,163(11):1285-1293.
  • 6Bounameaux H,de Moerloose P,Sarasin FP.Optimal duration of oral anticoagulant therapy following deep vein thrombosis of lower limbs.Blood Coagul Fibrinolysis,1996,7(5):507-614.
  • 7Campbell IA,Bentley DP,Prescott RJ,et al.Anticoagulation for three versus six months in patients with deep vein thrombosis or pulmonary embolism,or both:randomised trial.BMJ,2007,334(7595):674.
  • 8Ruiz-Gimenez N,Suarez C,Gonzalez R,et al.Predictive variables for major bleeding events in patients presenting with documented acute venous thromboembolism.Findings from the RIETE Registry.Thromb Haemost,2008,100(1):26-31.
  • 9Kearon C,Kahn SR,Agnelli G,et al.Antithrombotic therapy for venous thromboembolic disease:American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).Chest,2008,133 (6 Suppl):454S-545S.
  • 10Palareti G,Legnani C,Cosmi B,et al.Risk of venous thromboembolism recurrence:high negative predictive value of D-dimer performed after oral anticoagutation is stopped.Thromb Haemost,2002,87(1):7-12.

共引文献1710

同被引文献20

引证文献3

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部